{"schemaVersion":1,"profileUrl":"https://nowen.ai/agents/rtihs-org","markdownUrl":"https://nowen.ai/agents/rtihs-org.md","jsonUrl":"https://nowen.ai/agents/rtihs-org.json","name":"RTI Health Solutions","nickname":"RTI-HS","website":"https://rtihs.org","location":"Durham, North Carolina, United States","address":{"city":"Durham","state":"North Carolina","country":"United States"},"industry":"Healthcare Research","deliveryModel":"services","status":{"trust":"unclaimed","text":"Unclaimed: compiled by Nowen from public sources, not reviewed by the company"},"updatedAt":"2026-11-04T18:57:06.693Z","summary":"RTI Health Solutions provides research and consulting services to help life science and healthcare stakeholders make evidence-based decisions.","description":"RTI Health Solutions is an independent, nonprofit research and consulting organization serving life science and healthcare stakeholders. Its multidisciplinary researchers provide scientific evidence, strategic advice, and communication support to help pharmaceutical, biotechnology, and medical device organizations address development, regulatory, market access, safety, and patient-outcome questions. The organization combines rigorous research methods with industry context to support evidence-based healthcare decisions.","mission":"To improve the human condition by turning knowledge into practice.","directory":{"industryName":"Healthcare Research","agentCount":5,"indexable":false,"hubUrl":"https://nowen.ai/industry/healthcare-research"},"aiReaderFamilies":["Perplexity","Meta","Amazon"],"boonFrontDoor":{"url":"https://boon.ai/agents/rtihs-org","label":"Become a supplier to RTI Health Solutions through Boon","sub":"Your AI agent prepares the application."},"products":[{"name":"Value, Access, and HEOR Consulting","anchor":"product-value-access-and-heor-consulting","type":"Service","url":"https://www.rtihs.org/value-access-and-heor","summary":"Helps life sciences and medtech teams demonstrate product value, navigate market access requirements, and support reimbursement decisions with evidence.","description":"RTI Health Solutions provides value, access, and HEOR consulting and research for pharmaceutical, biotechnology, and medtech companies. Services help teams assess and communicate product value, evaluate market access considerations, and support reimbursement decisions throughout the product lifecycle. The work spans health economics, value and access strategy, HTA and reimbursement submissions, and outcomes research, using methods such as economic modeling, real-world data, statistical analysis, and primary research.","pricing":{},"features":[{"name":"Health economics modeling and research","value":"Assess Value And Inform Economic Decisions","valueDescription":"Builds evidence-based assessments of product value to inform healthcare decisions, market access, reimbursement, and HTA submissions."},{"name":"HTA and reimbursement submissions","value":"Develop Submissions For Global Market Access","valueDescription":"Helps pharmaceutical and medtech companies prepare submissions and dossiers that demonstrate product value, meet payer needs, and address global market access requirements."},{"name":"Value and access strategy","value":"Guide Product Value And Access Planning","valueDescription":"Supports clinical and commercial teams in shaping evidence-based strategies and tactics to communicate product value and pursue market access."},{"name":"HTA and payer value dossiers","value":"Present Evidence To Healthcare Decision-Makers","valueDescription":"Provides structured, evidence-based dossiers that communicate product value to stakeholders and support payer formulary decisions."},{"name":"Market access evidence roadmaps","value":"Identify Evidence Needs For Reimbursement","valueDescription":"Clarifies where additional evidence generation can support reimbursement decisions and improve product access."},{"name":"Value communication materials","value":"Communicate Product Value To Relevant Audiences","valueDescription":"Turns research findings and value messages into communication materials intended to support understanding and adoption by relevant audiences."},{"name":"Expert perspective research","value":"Understand Decision-Maker Perspectives","valueDescription":"Surfaces expert and stakeholder perspectives that can inform pricing, reimbursement, access, evidence planning, and product strategy."},{"name":"Outcomes research","value":"Evaluate Real-World Product Outcomes","valueDescription":"Provides evidence about how products are used and their value and safety in real-world settings to inform product and healthcare decisions."},{"name":"Evidence synthesis","value":"Synthesize Evidence And Identify Gaps","valueDescription":"Brings together existing research to clarify what is known, reveal evidence gaps, and support development and healthcare decisions."},{"name":"Health economics and outcomes research methods","value":"Generate Evidence Across Research Questions","valueDescription":"Uses a range of research methods and data sources to address questions about product development, market access, reimbursement, treatment effectiveness, and healthcare decision-making."},{"name":"Pricing and ICER support","value":"Address Pricing And ICER Considerations","valueDescription":"Supports product value and pricing considerations in relation to ICER's evolving landscape."},{"name":"Health equity","value":"Address Equity Across The Product Lifecycle","valueDescription":"Integrates health equity considerations with innovation across the pharmaceutical lifecycle."}]},{"name":"Patient-Centered Research","anchor":"product-patient-centered-research","type":"Service","url":"https://www.rtihs.org/patient-centered-research","summary":"Turns patient perspectives and preferences into evidence that supports product development, regulatory decisions, and strategic choices.","description":"RTI Health Solutions’ patient-centered research services capture, quantify, and apply the patient perspective throughout the product lifecycle. The multidisciplinary team develops actionable patient, provider, and caregiver insights to support product development, regulatory submissions, and strategic decision-making. Services include clinical outcome assessment strategy and development, patient-reported outcomes research, health preference studies, and benefit-risk assessment.","pricing":{},"features":[{"name":"Patient perspective research","value":"Apply Patient Perspectives To Decisions","valueDescription":"Uses actionable insights from patients, providers, and caregivers to inform product development, regulatory submissions, and strategic decisions."},{"name":"Clinical outcome assessment strategy","value":"Align Outcomes With Patient And Regulatory Needs","valueDescription":"Develops a clinical outcome assessment strategy that reflects patient experience while aligning with regulatory requirements."},{"name":"Clinical outcome assessment development and validation","value":"Develop And Validate Outcome Measures","valueDescription":"Creates or adapts outcome measures that reflect patient experiences and support product approval and labeling claims."},{"name":"Health preference studies","value":"Quantify Patient Treatment Preferences","valueDescription":"Clarifies patient priorities and treatment trade-offs to inform product development, positioning, and regulatory decisions."},{"name":"Patient outcome data collection","value":"Capture Patient Outcomes Across Research Settings","valueDescription":"Collects patient-reported information in clinical trials, observational studies, and clinical practice to support product claims, market access, and patient-clinician communication."},{"name":"Benefit-risk assessment","value":"Balance Product Benefits And Risks","valueDescription":"Assesses product benefits and risks in a way that addresses regulatory, reimbursement, and healthcare provider needs."},{"name":"Literature reviews","value":"Identify Evidence Gaps","valueDescription":"Reviews existing scientific findings to clarify what is known, identify gaps, and inform development decisions."}]},{"name":"Regulatory and safety consulting","anchor":"product-regulatory-and-safety-consulting","type":"Service","url":"https://www.rtihs.org/regulatory-and-safety","summary":"Generates rigorous safety and regulatory evidence to guide product development, support submissions, and inform post-approval decisions.","description":"RTI Health Solutions provides scientifically rigorous regulatory and safety consulting for pharmaceutical, biotech, and medical device companies. Its multidisciplinary team of pharmacoepidemiologists and biostatisticians supports product development, regulatory submissions, and post-approval activities through epidemiology research, statistical analysis, real-world evidence, and regulatory strategy. Services include evidence planning, submission preparation, regulatory agency interactions, post-authorization studies, and risk management support. Research approaches include observational studies, database and registry research, literature reviews, meta-analyses, and prospective studies.","pricing":{},"features":[{"name":"Epidemiology research","value":"Assess Disease Patterns And Treatment Impact","valueDescription":"Uses epidemiologic research to examine disease indicators, treatment impact, and patient outcomes, supporting development, regulatory submissions, and post-market safety activities."},{"name":"Regulatory strategy and agency support","value":"Navigate Regulatory Requirements And Submissions","valueDescription":"Provides strategic and scientific guidance for evidence requirements, submission preparation, and regulatory agency interactions throughout product development and after authorization."},{"name":"Biostatistical support","value":"Analyze Data For Regulatory Decisions","valueDescription":"Applies statistical methods and tools to clinical trial and observational data to generate evidence for regulatory, safety, and market access decisions."},{"name":"Post-authorization studies","value":"Strengthen Post-Approval Safety Evidence","valueDescription":"Generates evidence about product safety and effectiveness after authorization while supporting regulatory obligations and post-approval strategies."},{"name":"Real-world evidence strategy","value":"Apply Real-World Evidence Across Development","valueDescription":"Develops an approach to using real-world data at different stages of product development and supports regulatory decision-making and post-approval activities."},{"name":"Clinical outcome assessment support","value":"Develop And Support Outcome Measures","valueDescription":"Develops or revises outcome measures and supporting evidence with attention to regulatory agency expectations and their use in clinical trials and labeling strategies."},{"name":"Benefit-risk assessment","value":"Evaluate Product Benefits And Risks","valueDescription":"Assesses product benefits and risks to inform regulatory and healthcare decisions and address reimbursement and provider needs."},{"name":"Study planning and execution support","value":"Plan And Coordinate Rigorous Studies","valueDescription":"Assesses study feasibility, develops scientifically rigorous and regulatorily aligned protocols, and coordinates pharmacoepidemiologic investigations from planning through delivery."},{"name":"Regulatory-grade research collaborations","value":"Combine Data And Research Expertise","valueDescription":"Draws on research collaborations and multi-country real-world data to produce rigorous, transparent evidence supporting safety and effectiveness insights."}]},{"name":"Medical Communications","anchor":"product-medical-communications","type":"Service","url":"https://www.rtihs.org/medical-communications","summary":"Turns complex evidence into clear, credible communications that inform audiences, support scientific exchange, and advance understanding across the product lifecycle.","description":"RTI Health Solutions provides medical communications consulting and engagement strategy to translate complex clinical and scientific evidence into clear, audience-appropriate communications. Services span strategic planning, integrated evidence strategy, expert research, medical writing and publication planning, medical education, and creative and digital solutions. Multidisciplinary teams develop customized, scientifically rigorous communications for healthcare and scientific audiences, including providers, patients, and families, across the product lifecycle.","pricing":{},"features":[{"name":"Integrated evidence strategy","value":"Align Evidence Across The Product Lifecycle","valueDescription":"Connects evidence planning and execution with communication expertise to support continuity of outcomes throughout the product lifecycle."},{"name":"Medical writing and publication strategy","value":"Communicate Research With Clarity And Credibility","valueDescription":"Supports publication goals and communicates research to the right audiences through tailored writing, editing, and publication materials."},{"name":"Creative and digital scientific communications","value":"Make Scientific Data Clear And Engaging","valueDescription":"Presents accurate scientific information through audience-focused design and digital experiences intended to help audiences understand, remember, and act on the data."},{"name":"Audience-appropriate communication","value":"Tailor Evidence To Audience Needs","valueDescription":"Adapts scientific communications to the intended audience so complex evidence is presented clearly and appropriately."},{"name":"Expert stakeholder insights","value":"Inform Strategy With Stakeholder Perspectives","valueDescription":"Uses targeted research to understand stakeholder beliefs, competitor positioning, and evidence needs, and translates those insights into strategies."},{"name":"Medical education programs","value":"Turn Complex Evidence Into Practical Learning","valueDescription":"Supports disease understanding, contextualizes emerging data, and promotes knowledge retention and practical application through education formats."},{"name":"Scientific exchange and engagement planning","value":"Support Meaningful Scientific Exchange","valueDescription":"Plans audience engagement across formats such as congresses, advisory boards, field medical interactions, and digital education."},{"name":"Communication impact analytics","value":"Measure And Refine Communication Impact","valueDescription":"Uses analytics to assess communication impact and inform refinements to creative and digital solutions."}]},{"name":"Real-world evidence research and consulting","anchor":"product-real-world-evidence-research-and-consulting","type":"Service","url":"https://www.rtihs.org/real-world-evidence","summary":"Generates and applies real-world evidence to inform product development, regulatory decisions, market access, reimbursement, and outcomes research.","description":"RTI Health Solutions provides real-world evidence research and consulting to pharmaceutical, biotech, and medical device companies throughout the product lifecycle. Its services include evidence strategy, database and registry research, primary data collection, and research collaborations. The team develops research approaches using real-world data to support product development, regulatory decision-making, market access, reimbursement, safety activities, and outcomes research.","pricing":{},"features":[{"name":"Real-world evidence strategy","value":"Guide Evidence Generation Across The Product Lifecycle","valueDescription":"Helps organizations determine how to use real-world data to address research questions and support decisions at different stages of product development and use."},{"name":"Database and registry research","value":"Turn Real-World Data Into Actionable Evidence","valueDescription":"Enables research using database and registry sources to address questions about treatments, diseases, healthcare resource use, and patient outcomes."},{"name":"Regulatory real-world evidence strategy","value":"Align Evidence Approaches With Regulatory Needs","valueDescription":"Helps clients interpret relevant real-world evidence guidelines and plan research approaches for development, regulatory decision-making, and post-authorization activities."},{"name":"Primary data collection","value":"Capture Evidence From Patients And Care Teams","valueDescription":"Supports observational research that gathers information directly through cohort studies and surveys involving patients, physicians, or caregivers."},{"name":"Research collaborations","value":"Combine Data And Expertise Across Research Partners","valueDescription":"Research partnerships support multi-country studies and evidence generation on treatment safety and effectiveness, with an emphasis on methodological rigor and transparency."},{"name":"Post-authorization studies","value":"Support Post-Authorization Safety And Evidence Needs","valueDescription":"Provides study support to address safety, efficacy validation, and regulatory obligations after a product has been authorized."},{"name":"External control arm analysis","value":"Evaluate Treatments With Real-World Comparators","valueDescription":"Supports treatment evaluation by developing external control arm analyses using real-world evidence, including for single-arm trial comparators."},{"name":"Study design and protocol development","value":"Design Rigorous Studies For Research Objectives","valueDescription":"Helps translate research questions into study designs and protocols intended to meet scientific and regulatory requirements while considering project constraints."},{"name":"Chart data research","value":"Use Clinical Records To Address Research Questions","valueDescription":"Helps clients study clinical chart information as part of real-world research, including when special data protections are required."},{"name":"Research feasibility assessment","value":"Assess Study Feasibility Before Research Begins","valueDescription":"Provides information on practical study requirements and constraints, including timelines, costs, patient availability, and data source reliability."},{"name":"Study coordination","value":"Coordinate Pharmacoepidemiology Studies From Planning To Delivery","valueDescription":"Supports study execution by coordinating pharmacoepidemiologic investigations across their planning and delivery stages."},{"name":"Survey research","value":"Measure Health And Treatment Patterns Over Time","valueDescription":"Uses cross-sectional and longitudinal surveys to describe current disease and treatment patterns or examine changes in health, treatment response, and outcomes."},{"name":"Causal inference and target trial emulation","value":"Apply Target Trial Emulation To Real-World Data","valueDescription":"Uses the target trial emulation framework to support real-world data analysis and address methodological challenges."},{"name":"Site-based observational studies","value":"Combine Clinical Assessments With Patient Insights","valueDescription":"Brings together in-person clinical assessments and structured survey information in observational research."}]},{"name":"Medical Affairs Solutions","anchor":"product-medical-affairs-solutions","type":"Service","url":"https://www.rtihs.org/medical-affairs","summary":"Aligns evidence, communications, and stakeholder engagement to support informed healthcare decisions and stronger launch and lifecycle execution.","description":"RTI Health Solutions provides patient-centered medical affairs strategy and services to support evidence-based healthcare decisions and scientific exchange across the product lifecycle. Its multidisciplinary offerings include integrated evidence planning, expert and stakeholder research, medical education, scientific communications, launch readiness, and digital engagement. The work aligns evidence narratives, stakeholder needs, and global and local activities to help scientific innovations reach the right patients in the right context.","pricing":{},"features":[{"name":"Integrated evidence planning and generation","value":"Plan And Generate Integrated Evidence","valueDescription":"Connects evidence planning with design, generation, delivery, and communication to support continuity of outcomes throughout the product lifecycle."},{"name":"Medical strategy and positioning","value":"Shape Evidence-Based Medical Strategy","valueDescription":"Develops medical strategy and positioning that reflect evidence and stakeholder needs, supporting healthcare decisions and scientific exchange."},{"name":"Stakeholder research and insights","value":"Uncover Stakeholder Perspectives","valueDescription":"Gathers perspectives from experts, payers, providers, and other stakeholders through primary research and mapping to inform evidence plans and strategy."},{"name":"Medical education and training","value":"Translate Evidence Into Practical Learning","valueDescription":"Creates clear, interactive learning experiences intended to promote knowledge retention and practical application, support disease understanding, and inform decisions across the care pathway."},{"name":"Launch and lifecycle readiness","value":"Support Launch And Lifecycle Readiness","valueDescription":"Coordinates medical affairs planning and execution to support product launch and ongoing lifecycle activities."},{"name":"Scientific communications and content development","value":"Communicate Scientific Evidence Clearly","valueDescription":"Turns complex evidence into audience-appropriate scientific communications and content to support understanding and meaningful scientific exchange."},{"name":"Global-local and cross-functional alignment","value":"Align Global, Local, And Cross-Functional Teams","valueDescription":"Connects global and local activities and facilitates cross-functional alignment to support coordinated medical affairs planning and execution."},{"name":"Publication planning and delivery","value":"Plan And Deliver Scientific Publications","valueDescription":"Coordinates publication activities and related content to communicate evidence as part of a broader medical affairs strategy."},{"name":"Congress planning and experiences","value":"Create Engaging Congress Experiences","valueDescription":"Plans congress activities and develops booth designs and interactives to support scientific engagement with stakeholders."},{"name":"Digital engagement and reporting","value":"Engage Stakeholders And Track Impact","valueDescription":"Uses online platforms and digital engagement approaches to connect with stakeholders, with metrics and reporting to assess and refine impact."},{"name":"Landscape and competitor intelligence","value":"Assess Landscape And Competitors","valueDescription":"Uses landscape and competitor intelligence to inform medical strategy, positioning, and planning."},{"name":"Patient journey and social sentiment analysis","value":"Understand Patient Journeys And Sentiment","valueDescription":"Uses patient journey and social sentiment analysis to inform medical affairs planning and stakeholder engagement."}]},{"name":"Joint Clinical Assessment Services","anchor":"product-joint-clinical-assessment-services","type":"Service","url":"https://www.rtihs.org/joint-clinical-assessment","summary":"Prepares stronger EU JCA submissions with strategic planning, robust evidence generation, and support adapting to assessment scope and national HTA needs.","description":"RTI Health Solutions provides strategic and technical support to help drug and device developers prepare for and navigate the EU Joint Clinical Assessment process. Services span early planning, submission strategy, evidence generation and synthesis, and dossier preparation. The team helps anticipate assessment scope, address JCA and national HTA interdependencies, and develop robust evidence strategies aligned with stakeholder needs.","pricing":{},"features":[{"name":"JCA strategy and planning","value":"Build A Prepared Submission Strategy","valueDescription":"Develops a JCA strategy and preparatory activities for different assessment scenarios, with early consideration of scope, evidence needs, consultation, and organizational readiness."},{"name":"JCA evidence generation and synthesis","value":"Generate Submission-Ready Evidence","valueDescription":"Develops scientifically rigorous evidence for JCA submissions and a credible value story while addressing methodological requirements and stakeholder evidence needs."},{"name":"PICO prediction","value":"Anticipate Assessment Scope","valueDescription":"Prepares for likely and appropriate PICOs before final scope is confirmed, enabling focused evidence generation and planning for potential scope or label changes."},{"name":"JCA dossier preparation","value":"Prepare And Refine JCA Dossiers","valueDescription":"Builds submission readiness through advance preparation and dossier refinement, with support to adapt materials when final scope or label changes."},{"name":"Integrated evidence generation","value":"Align Evidence Across Requirements","valueDescription":"Plans evidence generation with JCA and national HTA requirements in view, helping teams coordinate their approach across stakeholder needs."},{"name":"Joint Scientific Consultation","value":"Gather Coordinated Multi-Country Input","valueDescription":"Obtains coordinated input on clinical development plans before pivotal trial parameters are finalized, with support that can include mock consultations."},{"name":"Organizational readiness and training","value":"Assess Readiness And Train Teams","valueDescription":"Evaluates organizational readiness and provides training to help teams prepare for JCA requirements and submission activities."}]},{"name":"Implementation science services","anchor":"product-implementation-science-services","type":"Service","url":"https://www.rtihs.org/implementation-science","summary":"Anticipates adoption challenges and aligns evidence, stakeholders, and healthcare systems so innovations can reach patients in real-world practice.","description":"RTI Health Solutions provides multidisciplinary implementation science services to help pharmaceutical, biotech, and medtech companies bridge the gap between clinical development and real-world healthcare adoption. The team combines insights from clinical research, Medical Affairs, real-world evidence, health economics, and stakeholder engagement in a systems-thinking approach. Using established frameworks and rigorous analytics, they identify factors that support or hinder adoption and develop tailored strategies that connect scientific evidence, market dynamics, provider practices, patient perspectives, and policy environments.","pricing":{},"features":[{"name":"Implementation barrier assessment","value":"Identify Adoption Barriers Early","valueDescription":"Pinpoints factors that may prevent providers, patients, payers, or health systems from adopting a therapy, allowing teams to address real-world challenges proactively."},{"name":"Cross-functional implementation strategy","value":"Align Teams Around Adoption","valueDescription":"Connects expertise and perspectives across relevant functions so implementation considerations are addressed together rather than in silos."},{"name":"Early implementation planning","value":"Plan For Uptake Before Launch","valueDescription":"Considers real-world adoption during development, giving teams the opportunity to use implementation needs to shape evidence generation and care pathway planning before launch."},{"name":"Tailored implementation strategies","value":"Tailor Strategies To Real-World Needs","valueDescription":"Translates findings about adoption conditions into strategies designed for the specific product and its stakeholder, market, and healthcare system context."},{"name":"Systems-thinking approach","value":"Connect Evidence And Care Systems","valueDescription":"Addresses relationships among evidence, stakeholders, market conditions, and healthcare systems to develop implementation strategies suited to the real-world context."}]}],"audiences":[],"segments":[{"name":"Health economics and market access consulting","description":"Research and consulting that help life sciences companies demonstrate clinical and economic value, prepare health technology assessments, and support pricing, reimbursement, and market access decisions.","size":1.5,"cagr":13.5,"color":1,"productNames":["Value, Access, and HEOR Consulting","Joint Clinical Assessment Services"],"methodology":"The closest available estimate is the global HEOR market: USD 1.50 billion in 2024, projected to grow at a 13.50% CAGR through 2034. This market includes services beyond consulting, so it is a proxy and may overstate the consulting-only segment.","citations":[{"url":"https://www.researchandmarkets.com/reports/5775109/health-economics-outcomes-research-heor-market?srsltid=AYCX9vJ6KmcRkLWO5D1RmJzl97SHcjYfWTAiuJWRmi5qcQLr08cVALHb","text":"The global health economics and outcomes research market was valued at USD 1.50 Billion in 2024… anticipated to grow at a CAGR of 13.50%"}]},{"name":"Real-world evidence","description":"Capabilities to aggregate, link, and analyze clinical and claims data to generate evidence for clinical research, regulatory submissions, and lifecycle evidence generation.","size":3.9,"cagr":11.1,"color":2,"productNames":["Real-world evidence research and consulting","Regulatory and safety consulting","Value, Access, and HEOR Consulting"],"methodology":"Estimated global market size is USD 3.9 billion in 2025, using Grand View Research’s estimate for real-world evidence solutions, which closely matches the described capabilities. Published estimates vary across providers and market definitions; reported growth rates range from 11.1% to 16.3%. The estimate uses Grand View Research’s 2026–2033 forecast CAGR of 11.1%.","citations":[{"url":"https://www.grandviewresearch.com/industry-analysis/real-world-evidence-solutions-market-report","text":"The global real world evidence solutions market size was valued at USD 3.9 billion in 2025 and is projected to grow from USD 4.3 billion to USD 9.0 billion by 2033, at a CAGR of 11.1%."},{"url":"https://www.gminsights.com/industry-analysis/real-world-evidence-solutions-market","text":"The global real world evidence solutions market was valued at USD 2.6 billion in 2025 and is projected to increase from USD 3.1 billion in 2026 to USD 11.9 billion by 2035, at a CAGR of 16.3%."}]},{"name":"Patient-centered outcomes research","description":"Research that helps product developers incorporate patient perspectives, develop and validate clinical outcome assessments, quantify treatment preferences, and support regulatory claims and benefit-risk decisions.","size":1.5,"cagr":13.5,"color":3,"productNames":["Patient-Centered Research","Regulatory and safety consulting"],"methodology":"The search results provide no standalone estimate for patient-centered outcomes research. The closest quantified proxy is the broader global health economics and outcomes research (HEOR) market, valued at USD 1.50 billion in 2024 and forecast to grow at 13.50% CAGR through 2034. Because the specified segment is narrower than HEOR, USD 1.50 billion should be treated as a broad-market proxy, not a direct segment estimate; the segment's actual size is likely smaller.","citations":[{"url":"https://www.researchandmarkets.com/reports/5775109/health-economics-outcomes-research-heor-market","text":"The global health economics and outcomes research market was valued at USD 1.50 Billion in 2024 ... anticipated to grow at a CAGR of 13.50%"}]},{"name":"Regulatory affairs and drug safety consulting","description":"Scientific and strategic support for life sciences companies preparing regulatory submissions, engaging agencies, assessing benefit-risk, and meeting post-authorization safety and evidence requirements.","size":7,"cagr":8.5,"color":4,"productNames":["Regulatory and safety consulting","Real-world evidence research and consulting"],"methodology":"Estimated global 2025 market for regulatory affairs and drug-safety consulting. The estimate uses the reported USD 5 billion 2025 regulatory consulting market as an anchor, adjusted upward for drug-safety consulting; broader regulatory affairs and pharmacovigilance market figures provide context but include activities beyond consulting. Growth is estimated at 8.5%, consistent with reported regulatory consulting, regulatory affairs, and pharmacovigilance growth rates.","citations":[{"url":"https://www.marketresearchfuture.com/reports/pharmaceutical-consulting-services-market-67543","text":"In 2025, the market for regulatory consulting is projected to reach approximately 5 billion USD, reflecting a compound annual growth rate of around 8 percent."},{"url":"https://www.cervicornconsulting.com/regulatory-affairs-market","text":"The global regulatory affairs market size was reached at USD 17.68 billion in 2025 and is expected to be worth around USD 40.13 billion by 2035, exhibiting a CAGR of 8.54%."},{"url":"https://www.futuremarketinsights.com/reports/pharmacovigilance-market","text":"Market value rises from USD 9 billion in 2025 to USD 9.8 billion in 2026 and USD 22.8 billion by 2036. CAGR 2026 to 2036 8.8%."}]},{"name":"Medical affairs and scientific communications","description":"Services that help life sciences teams plan medical strategy, communicate scientific evidence, educate and engage stakeholders, and address implementation barriers to product adoption across the lifecycle.","size":6.99,"cagr":5.8,"color":5,"productNames":["Medical Affairs Solutions","Medical Communications","Implementation science services"],"methodology":"The medical communication services estimate is the closest available proxy for this broader segment, covering scientific communication and related services. It reports a 2026 market size of USD 6.994 billion and a 5.8% CAGR through 2034. Medical writing is a related component, with separate estimates around USD 5.3–5.7 billion, so these figures should not be added to the proxy. The segment estimate is therefore approximate and may not capture all medical strategy and affairs services.","citations":[{"url":"https://www.linkedin.com/pulse/medical-communication-services-market-trends-2026-6wq6c","text":"Medical Communication Services Market is expected to grow from USD 6,994 million in 2026 to USD 9,749 million by 2034, expanding at a CAGR of 5.8%."},{"url":"https://www.maximizemarketresearch.com/market-report/medical-writing-market/125488/","text":"The Medical Writing Market size was valued at USD 5.33 Billion in 2025 and ... grow at a CAGR of 10.4% from 2025 to 2032."}]}],"faq":[],"comparisons":[],"sources":[{"url":"https://rtihs.org","text":"RTI Health Solutions"},{"url":"https://www.rtihs.org/value-access-and-heor","text":"Value, Access, and HEOR Consulting"},{"url":"https://www.rtihs.org/patient-centered-research","text":"Patient-Centered Research"},{"url":"https://www.rtihs.org/regulatory-and-safety","text":"Regulatory and safety consulting"},{"url":"https://www.rtihs.org/medical-communications","text":"Medical Communications"},{"url":"https://www.rtihs.org/real-world-evidence","text":"Real-world evidence research and consulting"},{"url":"https://www.rtihs.org/medical-affairs","text":"Medical Affairs Solutions"},{"url":"https://www.rtihs.org/joint-clinical-assessment","text":"Joint Clinical Assessment Services"},{"url":"https://www.rtihs.org/implementation-science","text":"Implementation science services"},{"url":"https://www.researchandmarkets.com/reports/5775109/health-economics-outcomes-research-heor-market?srsltid=AYCX9vJ6KmcRkLWO5D1RmJzl97SHcjYfWTAiuJWRmi5qcQLr08cVALHb","text":"The global health economics and outcomes research market was valued at USD 1.50 Billion in 2024… anticipated to grow at a CAGR of 13.50%"},{"url":"https://www.grandviewresearch.com/industry-analysis/real-world-evidence-solutions-market-report","text":"The global real world evidence solutions market size was valued at USD 3.9 billion in 2025 and is projected to grow from USD 4.3 billion to USD 9.0 billion by 2033, at a CAGR of 11.1%."},{"url":"https://www.gminsights.com/industry-analysis/real-world-evidence-solutions-market","text":"The global real world evidence solutions market was valued at USD 2.6 billion in 2025 and is projected to increase from USD 3.1 billion in 2026 to USD 11.9 billion by 2035, at a CAGR of 16.3%."},{"url":"https://www.researchandmarkets.com/reports/5775109/health-economics-outcomes-research-heor-market","text":"The global health economics and outcomes research market was valued at USD 1.50 Billion in 2024 ... anticipated to grow at a CAGR of 13.50%"},{"url":"https://www.marketresearchfuture.com/reports/pharmaceutical-consulting-services-market-67543","text":"In 2025, the market for regulatory consulting is projected to reach approximately 5 billion USD, reflecting a compound annual growth rate of around 8 percent."},{"url":"https://www.cervicornconsulting.com/regulatory-affairs-market","text":"The global regulatory affairs market size was reached at USD 17.68 billion in 2025 and is expected to be worth around USD 40.13 billion by 2035, exhibiting a CAGR of 8.54%."},{"url":"https://www.futuremarketinsights.com/reports/pharmacovigilance-market","text":"Market value rises from USD 9 billion in 2025 to USD 9.8 billion in 2026 and USD 22.8 billion by 2036. CAGR 2026 to 2036 8.8%."},{"url":"https://www.linkedin.com/pulse/medical-communication-services-market-trends-2026-6wq6c","text":"Medical Communication Services Market is expected to grow from USD 6,994 million in 2026 to USD 9,749 million by 2034, expanding at a CAGR of 5.8%."},{"url":"https://www.maximizemarketresearch.com/market-report/medical-writing-market/125488/","text":"The Medical Writing Market size was valued at USD 5.33 Billion in 2025 and ... grow at a CAGR of 10.4% from 2025 to 2032."}]}